Pillar Biosciences Receives Premarket Approval from FDA for its oncoReveal Dx Lung and Colon Cancer Assay
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
The goal for the project is the identification and optimization of anti-viral compounds.
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
AstraZeneca, Sinopharm and Moderna were part of the study
Five seats reserved for Wards of COVID warriors in central MBBS admission
Aditya Puri former MD of HDFC bank joins Solara board as chairman
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
Ayush Ministry will conduct the study along with the UK’s London School of Hygiene and Tropical Medicine
Subscribe To Our Newsletter & Stay Updated